1134327-76-6 Usage
General Description
Tert-butyl 4-(2-fluorobenzoyl)piperidine-1-carboxylate is a chemical compound with a complex structure, characterized by the presence of several functional groups. By its nomenclature, this compound includes a tert-butyl group, a fluorobenzoyl group, and a piperidine ring, along with carboxylate functionality. The presence of the fluorobenzoyl group suggests that the compound has a degree of reactivity and could be involved in various chemical reactions. This specific structure means the compound might interact in specific ways with biological systems, and its properties could be exploited in the pharmaceutical industry, in material science, and more generally in all sectors where organic chemistry finds application. An important aspect of this compound could be its potential to be synthesized through controlled reactions, which make it a compound of interest for several research purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 1134327-76-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,4,3,2 and 7 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1134327-76:
(9*1)+(8*1)+(7*3)+(6*4)+(5*3)+(4*2)+(3*7)+(2*7)+(1*6)=126
126 % 10 = 6
So 1134327-76-6 is a valid CAS Registry Number.
1134327-76-6Relevant articles and documents
QUINOXALINE DERIVATIVES AS GPR6 MODULATORS
-
Paragraph 0229-0232, (2014/03/22)
The present invention provides compounds of Formula (I) that are GPR6 modulators and are therefore useful for the treatment of diseases treatable by modulation of GPR6, in particular treating Parkinson disease, levodopa induced dyskinesias, Huntington's disease, other dyskinesias, akinesias, and motor disorders involving dysfunction of the striatum, schizophrenia and drug addiction. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
